NZ503862A - Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia - Google Patents

Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia

Info

Publication number
NZ503862A
NZ503862A NZ503862A NZ50386298A NZ503862A NZ 503862 A NZ503862 A NZ 503862A NZ 503862 A NZ503862 A NZ 503862A NZ 50386298 A NZ50386298 A NZ 50386298A NZ 503862 A NZ503862 A NZ 503862A
Authority
NZ
New Zealand
Prior art keywords
hyperglycaemia
treatment
thiazolidinediones
insulin sensitisers
insulin
Prior art date
Application number
NZ503862A
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NZ503862A publication Critical patent/NZ503862A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

A method for the treatment of hyperglycaemia wherein plasma glucose levels are in the range from elevated normal to < 126mg/dl, the method comprising administering to a mammal an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser.
NZ503862A 1997-10-13 1998-10-12 Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia NZ503862A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number Publication Date
NZ503862A true NZ503862A (en) 2003-01-31

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ503862A NZ503862A (en) 1997-10-13 1998-10-12 Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (en)
JP (1) JP2001519382A (en)
KR (1) KR20010024481A (en)
CN (1) CN1281359A (en)
AP (1) AP2000001787A0 (en)
AU (1) AU9547098A (en)
BG (1) BG104404A (en)
BR (1) BR9815219A (en)
CA (1) CA2306086A1 (en)
CZ (1) CZ20001297A3 (en)
EA (1) EA002659B1 (en)
GB (1) GB9721693D0 (en)
HR (1) HRP20000255A2 (en)
HU (1) HUP0003922A3 (en)
ID (1) ID24521A (en)
IL (1) IL135513A0 (en)
NO (1) NO20001898L (en)
NZ (1) NZ503862A (en)
OA (1) OA11683A (en)
PL (1) PL339813A1 (en)
SK (1) SK5312000A3 (en)
TR (1) TR200000958T2 (en)
WO (1) WO1999018943A1 (en)
YU (1) YU28800A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
BR9815219A (en) 2001-01-02
CA2306086A1 (en) 1999-04-22
OA11683A (en) 2005-01-12
AU9547098A (en) 1999-05-03
IL135513A0 (en) 2001-05-20
CZ20001297A3 (en) 2001-08-15
JP2001519382A (en) 2001-10-23
PL339813A1 (en) 2001-01-02
HRP20000255A2 (en) 2001-02-28
KR20010024481A (en) 2001-03-26
SK5312000A3 (en) 2000-09-12
BG104404A (en) 2000-12-29
ID24521A (en) 2000-07-20
HUP0003922A3 (en) 2001-12-28
GB9721693D0 (en) 1997-12-10
HUP0003922A2 (en) 2001-10-28
EA200000419A1 (en) 2000-10-30
TR200000958T2 (en) 2000-08-21
NO20001898L (en) 2000-06-09
EA002659B1 (en) 2002-08-29
YU28800A (en) 2003-02-28
EP1023056A1 (en) 2000-08-02
WO1999018943A1 (en) 1999-04-22
CN1281359A (en) 2001-01-24
AP2000001787A0 (en) 2000-06-30
NO20001898D0 (en) 2000-04-12

Similar Documents

Publication Publication Date Title
EP1787646A3 (en) Novel method of treatment
YU37301A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
AP2002002703A0 (en) Combinations of depeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diadetes mellitus.
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
AP2001002291A0 (en) Novel method of treatment.
WO2000007575A3 (en) Methods and compositions for increasing insulin sensitivity
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
AP9901720A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors.
MY125855A (en) Treatment of diabetes with a thiazolidinedione and sulphonylurea
IL126725A0 (en) Compositions comprising a nitrone compound for use in treating ocular inflammation
MY138246A (en) Treatment of diabetes with thiazolidione and sulphonylurea.
NZ503862A (en) Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
CO5280202A1 (en) TREATMENT METHODS AND TRAFFIC METHODS OF PHARMACOS
TR200101336T2 (en) Combinations with a beta-agonist and another antidiabetic agent
YU28700A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
MX9701606A (en) Combination therapy to prevent bone loss- progesterone and strogen.
PL327472A1 (en) Nitrogen oxide (no) synthase inhibitor for use in treatment or polphylaxy of type ii diabetes
MY118982A (en) Method of reducing tissue damage associated with ischemia
CA2350425A1 (en) Use of an insulin sensitiser for the treatment of type 2 diabetes mellitus
HUP0002569A2 (en) Pharmaceutical compositions for treatment of diabetes containing thiazolidinedione and alpha-glucosidase inhibitors
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
HUP0002669A2 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)